Current Highlight from July 4, 2014
Effect of Silver Nanoparticles on the Gut Microbes and Intestinal Immune Responses
NCTR scientists have shown that silver nanoparticles, administered by oral gavage, caused size- and dose-dependent changes in the gastrointestinal microbiota and the gut-associated immune response of rats; with smaller nanoparticles demonstrating the greatest antimicrobial capability. Silver nanoparticles are widely used in the food and health care industry due to their antimicrobial properties; however, the effects of oral ingestion of nanosilver are largely unknown. This study suggests that the microbiome may need to be considered in the safety evaluation of nanotechnology-derived products. This would be added to traditional metabolism, toxicity, and tissue-deposition information currently used in toxicology risk assessments. This study, which is part of a National Toxicology Program 13-week study, is currently published online at Nanotoxicology.
For additional information, please contact Sangeeta Khare, Ph.D., Division of Microbiology, FDA/NCTR.
NCTR Research Highlights Archives
Contact FDA
870-543-7000
National Center for Toxicological Research
Food and Drug Administration
3900 NCTR Road
Jefferson, AR 72079
No hay comentarios:
Publicar un comentario